Asthma in Canada: missing the treatment targets

著者: Chapman, Kenneth R.
出版事項 2008

Increasing Awareness of COPD: Two Steps Forward, One Step Back

著者: Chapman, Kenneth R.
出版年 Chronic Obstr Pulm Dis (2018)

Bench to Bedside and Back: The Evolving Story of Alpha-1 Antitrypsin Deficiency

著者: Chapman, Kenneth R.
出版年 Am J Respir Cell Mol Biol (2020)

Comparative efficacy of indacaterol in chronic obstructive pulmonary disease

著者: Ribeiro, Marcos, Chapman, Kenneth R
出版事項 2012

Asthma that is unresponsive to usual care

著者: Chapman, Kenneth R., McIvor, Andrew
出版事項 2010

Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease

著者: Brode, Sarah K., Ling, Simon C., Chapman, Kenneth R.
出版事項 2012

Types, frequency and impact of asthma triggers on patients’ lives: a quantitative study in five European countries

著者: Price, David, Dale, Peter, Elder, Emma, Chapman, Kenneth R.
出版事項 2014

α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action

著者: Yang, Chengliang, Chapman, Kenneth R, Wong, Aaron, Liu, Mingyao
出版年 Lancet Respir Med (2021)

Overall and Cardiovascular Safety of Aclidinium Bromide in Patients With COPD: A Pooled Analysis of Six Phase III, Placebo-Controlled, Randomized Studies

著者: Chapman, Kenneth R., Beck, Ekkehard, Alcaide, Daniel, Garcia Gil, Esther
出版年 Chronic Obstr Pulm Dis (2015)

The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis

著者: Miravitlles, Marc, Chapman, Kenneth R, Chuecos, Ferran, Ribera, Anna, Gil, Esther Garcia
出版年 Int J Chron Obstruct Pulmon Dis (2016)

Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence base

著者: D’Urzo, Anthony D., Singh, Dave, Donohue, James F., Chapman, Kenneth R.
出版年 Ther Adv Respir Dis (2019)

Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal

著者: Chapman, Kenneth R, Barnes, Neil C, Greening, Andrew P, Jones, Paul W, Pedersen, S
出版事項 2010

Mortality among subjects with chronic obstructive pulmonary disease or asthma at two respiratory disease clinics in Ontario

著者: Finkelstein, Murray M, Chapman, Kenneth R, McIvor, R Andrew, Sears, Malcolm R
出版事項 2011

Le rôle de l’omalizumab dans le traitement de l’asthme allergique grave

著者: Chapman, Kenneth R, Cartier, André, Hébert, Jacques, McIvor, R Andrew, Schellenberg, R Robert
出版事項 2006

The role of omalizumab in the treatment of severe allergic asthma

著者: Chapman, Kenneth R, Cartier, Andre, Hébert, Jacques, McIvor, R Andrew, Schellenberg, R Robert
出版事項 2006

Infection with Mycoplasma pneumoniae is not related to asthma control, asthma severity, and location of airway obstruction

著者: Ansarin, Khalil, Abedi, Siavoush, Ghotaslou, Reza, Soroush, Mohammad Hossein, Ghabili, Kamyar, Chapman, Kenneth R
出版事項 2010

QVA149 Improves Lung Function, Dyspnea, and Health Status Independent of Previously Prescribed Medications and COPD Severity: A Subgroup Analysis from the SHINE and ILLUMINATE Stud...

著者: Chapman, Kenneth R., Bateman, Eric D., Chen, Hungta, Hu, Hulin, Fogel, Robert, Banerji, Donald
出版年 Chronic Obstr Pulm Dis (2015)

Predicting the need for supplemental oxygen during airline flight in patients with chronic pulmonary disease: A comparison of predictive equations and altitude simulation

著者: Bradi, Ana C, Faughnan, Marie E, Stanbrook, Matthew B, Deschenes-Leek, Eva, Chapman, Kenneth R
出版事項 2009

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications

著者: Chapman, Kenneth R, Chorostowska-Wynimko, Joanna, Koczulla, A Rembert, Ferrarotti, Ilaria, McElvaney, Noel G
出版年 Int J Chron Obstruct Pulmon Dis (2018)

Asthma control in Canada: No improvement since we last looked in 1999

著者: McIvor, R. Andrew, Boulet, Louis-Philippe, FitzGerald, J. Mark, Zimmerman, Sabrina, Chapman, Kenneth R.
出版事項 2007